C. Fitzmaurice, C. Allen, R. M. Barber, L. Barregard, Z. A. Bhutta et al., Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, Global Burden of Disease Cancer, vol.3, pp.524-548, 1990.

M. J. Duffy, N. Harbeck, M. Nap, R. Molina, A. Nicolini et al., Clinical Use of Biomarkers in Breast Cancer: Updated Guidelines from the European Group on Tumor Markers (Egtm), Eur. J. Cancer, vol.75, pp.284-298, 2017.

I. A. Murray, A. D. Patterson, and G. H. Perdew, Aryl Hydrocarbon Receptor Ligands in Cancer: Friend and Foe, Nat. Rev. Cancer, vol.14, pp.801-814, 2014.

D. C. Bersten, A. E. Sullivan, D. J. Peet, and M. L. Whitelaw, Bhlh-Pas Proteins in Cancer, Nat. Rev. Cancer, vol.13, pp.827-841, 2013.

C. Dietrich, Antioxidant Functions of the Aryl Hydrocarbon Receptor, Stem Cells Int, vol.7943495, 2016.

M. B. Kumar, R. W. Tarpey, and G. H. Perdew, Differential Recruitment of Coactivator Rip140 by Ah and Estrogen Receptors. Absence of a Role for Lxxll Motifs, J. Biol. Chem, vol.274, pp.22155-22164, 1999.

P. Augereau, E. Badia, M. Fuentes, F. Rabenoelina, M. Corniou et al., Transcriptional Regulation of the Human Nrip1/Rip140 Gene by Estrogen Is Modulated by Dioxin Signalling, Mol. Pharmacol, vol.69, pp.1338-1346, 2006.

S. K. Kolluri, U. H. Jin, and S. Safe, Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as an Anti-Cancer Drug Target, Arch. Toxicol, vol.91, pp.2497-2513, 2017.

M. A. Barhoover, J. M. Hall, W. F. Greenlee, and R. S. Thomas, Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells Via a Functional Interaction with Cyclin-Dependent Kinase 4, Mol. Pharmacol, vol.77, pp.195-201, 2010.

Z. D. Li, K. Wang, X. W. Yang, Z. G. Zhuang, J. J. Wang et al., Expression of Aryl Hydrocarbon Receptor in Relation to P53 Status and Clinicopathological Parameters in Breast Cancer, Int. J. Clin. Exp. Pathol, vol.7, pp.7931-7937, 2014.

S. Vacher, P. Castagnet, W. Chemlali, F. Lallemand, D. Meseure et al., High Ahr Expression in Breast Tumors Correlates with Expression of Genes from Several Signaling Pathways Namely Inflammation and Endogenous Tryptophan Metabolism, PLoS ONE, vol.13, p.190619, 2018.

, Int. J. Mol. Sci, vol.20, p.1016, 2019.

E. F. O'donnell, D. C. Koch, W. H. Bisson, H. S. Jang, and S. K. Kolluri, The Aryl Hydrocarbon Receptor Mediates Raloxifene-Induced Apoptosis in Estrogen Receptor-Negative Hepatoma and Breast Cancer Cells, Cell Death Dis, vol.5, 1038.

J. B. Powell, G. D. Goode, and S. E. Eltom, The Aryl Hydrocarbon Receptor: A Target for Breast Cancer Therapy, J. Cancer Ther, vol.4, pp.1177-1186, 2013.

C. Bock, C. Kuhn, N. Ditsch, R. Krebold, S. Heublein et al., Strong Correlation between N-Cadherin and Cd133 in Breast Cancer: Role of Both Markers in Metastatic Events, J. Cancer Res. Clin. Oncol, vol.140, pp.1873-1881, 2014.

N. Ditsch, D. Mayr, M. Lenhard, C. Strauss, A. Vodermaier et al., Correlation of Thyroid Hormone, Retinoid X, Peroxisome Proliferator-Activated, Vitamin D and Oestrogen/Progesterone Receptors in Breast Carcinoma, Oncol. Lett, vol.4, pp.665-671, 2012.

N. Ditsch, B. Toth, I. Himsl, M. Lenhard, R. Ochsenkuhn et al., Thyroid Hormone Receptor (Tr)Alpha and Trbeta Expression in Breast Cancer, Histol. Histopathol, vol.28, pp.227-237, 2013.

S. Sixou, K. Muller, S. Jalaguier, C. Kuhn, N. Harbeck et al., Importance of Rip140 and Lcor Sub-Cellular Localization for Their Association with Breast Cancer Aggressiveness and Patient Survival, Transl. Oncol, vol.11, pp.1090-1096, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02292304

W. Remmele and H. E. Stegner, Recommendation for Uniform Definition of an Immunoreactive Score (Irs) for Immunohistochemical Estrogen Receptor Detection (Er-Ica) in Breast Cancer Tissue, Pathologe, vol.8, pp.138-140, 1987.

R. Saito, Y. Miki, S. Hata, K. Takagi, S. Iida et al., Aryl Hydrocarbon Receptor in Breast Cancer-a Newly Defined Prognostic Marker, Horm. Cancer, vol.5, pp.11-21, 2014.

A. F. Trombino, R. I. Near, R. A. Matulka, S. Yang, L. J. Hafer et al., Expression of the Aryl Hydrocarbon Receptor/Transcription Factor (Ahr) and Ahr-Regulated Cyp1 Gene Transcripts in a Rat Model of Mammary Tumorigenesis, Breast Cancer Res. Treat, vol.63, pp.117-131, 2000.

T. Ikuta, H. Eguchi, T. Tachibana, Y. Yoneda, and K. Kawajiri, Nuclear Localization and Export Signals of the Human Aryl Hydrocarbon Receptor, J. Biol. Chem, vol.273, pp.2895-2904, 1998.

T. Ikuta, T. Tachibana, J. Watanabe, M. Yoshida, Y. Yoneda et al., Nucleocytoplasmic Shuttling of the Aryl Hydrocarbon Receptor, J. Biochem, vol.127, pp.503-509, 2000.

T. Ikuta, J. Watanabe, and K. Kawajiri, Characterization of the Lxxll Motif in the Aryl Hydrocarbon Receptor: Effects on Subcellular Localization and Transcriptional Activity, J. Biochem, vol.131, pp.79-85, 2002.

M. Mandl, M. Lieberum, J. Dunst, and R. Depping, The Expression Level of the Transcription Factor Aryl Hydrocarbon Receptor Nuclear Translocator (Arnt) Determines Cellular Survival after Radiation Treatment, Radiat. Oncol, vol.10, p.229, 2015.

S. Luecke-johansson, M. Gralla, H. Rundqvist, J. C. Ho, R. S. Johnson et al., A Molecular Mechanism to Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase, Mol. Cell Biol, vol.37, pp.630-646, 2017.

C. H. Li, C. W. Liu, C. H. Tsai, Y. J. Peng, Y. H. Yang et al., Cytoplasmic Aryl Hydrocarbon Receptor Regulates Glycogen Synthase Kinase 3 Beta, Accelerates Vimentin Degradation, and Suppresses Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Cells, Arch. Toxicol, vol.91, pp.2165-2178, 2017.

N. Harbeck, U. Alt, U. Berger, A. Kruger, C. Thomssen et al., Prognostic Impact of Proteolytic Factors (Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor 1, and Cathepsins B, D, and L) in Primary Breast Cancer Reflects Effects of Adjuvant Systemic Therapy, Clin. Cancer Res, vol.7, pp.2757-2764, 2001.

Z. Madak-erdogan and B. S. Katzenellenbogen, Aryl Hydrocarbon Receptor Modulation of Estrogen Receptor Alpha-Mediated Gene Regulation by a Multimeric Chromatin Complex Involving the Two Receptors and the Coregulator Rip140, Toxicol. Sci, vol.125, pp.401-411, 2012.

N. L. Henry, P. L. Bedard, and A. Demichele, Standard and Genomic Tools for Decision Support in Breast Cancer Treatment, Am. Soc. Clin. Oncol, vol.37, pp.106-115, 2017.

J. J. Schlezinger, D. Liu, M. Farago, D. C. Seldin, K. Belguise et al., A Role for the Aryl Hydrocarbon Receptor in Mammary Gland Tumorigenesis, Biol. Chem, vol.387, pp.1175-1187, 2006.

B. Gyorffy, A. Lanczky, A. C. Eklund, C. Denkert, J. Budczies et al., An Online Survival Analysis Tool to Rapidly Assess the Effect of 22,277 Genes on Breast Cancer Prognosis Using Microarray Data of 1,809 Patients, Breast Cancer Res. Treat, vol.123, pp.725-731, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00520003

S. F. Madden, C. Clarke, P. Gaule, S. T. Aherne, N. O'donovan et al., Breastmark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome, Breast Cancer Res, vol.15, 2013.

E. W. Elston and I. O. Ellis, Method for Grading Breast Cancer, J. Clin. Pathol, vol.46, pp.189-190, 1993.

T. Weissenbacher, E. Hirte, C. Kuhn, W. Janni, D. Mayr et al., Multicentric and Multifocal Versus Unifocal Breast Cancer: Differences in the Expression of E-Cadherin Suggest Differences in Tumor Biology, BMC Cancer, vol.13, 2013.

I. Mylonas, J. Makovitzky, U. Jeschke, V. Briese, K. Friese et al., Expression of Her2/Neu, Steroid Receptors (Er and Pr), Ki67 and P53 in Invasive Mammary Ductal Carcinoma Associated with Ductal Carcinoma in Situ (Dcis) Versus Invasive Breast Cancer Alone, Anticancer Res, vol.25, pp.1719-1723, 2005.